A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Conditions
Malignant Peritoneal Mesothelioma · Peritoneal Mesothelioma · Mesothelioma · Mesothelioma, Malignant · Malignant Mesothelioma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Chicago (Data Collection Only), Chicago, Illinois, United States
University of Michigan (Data Collection Only), Ann Arbor, Michigan, United States
Washington University (Data Collection Only), St Louis, Missouri, United States
University of Nebraska (Data collection only), Omaha, Nebraska, United States
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
Rutgers University (Data Collection Only), New Brunswick, New Jersey, United States
Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York, United States
Memorial Sloan Kettering Westchester (Limited Protocol Activites), Harrison, New York, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States
Allegheny Health Network (Data Collection Only), Pittsburgh, Pennsylvania, United States
Study leads
Garrett Nash, MD
Principal Investigator
Memorial Sloan Kettering Cancer